In a strategic move aligning with its mission of promoting global health and safety, NSF International has announced the addition of two influential figures to its Board of Directors. Dean Bergy and Nancy Lurker, both celebrated for their extensive leadership in the life sciences industry, join NSF as it commemorates its 80th anniversary. This development was enthusiastically shared by NSF’s President and CEO, Pedro Sancha, underscoring the duo’s potential to significantly contribute to NSF’s ongoing commitment to enhancing human and planetary health.
Dean Bergy: A Blend of Financial Acumen and Health Sector Expertise
Dean Bergy’s illustrious career spans over 25 years at Stryker Corporation, a leader in medical technology. His tenure as Chief Financial Officer and Corporate Secretary, coupled with his status as a Certified Public Accountant, equips him with a unique blend of financial expertise and health sector insight. Bergy’s role in various committees, including the City of Kalamazoo’s Retirement Investment Committee and the Kalamazoo Institute of Arts Endowment Committee, further highlights his diverse skill set. His educational background, featuring a stint at Harvard Business School and a BBA from the University of Michigan, adds to his impressive profile.
Bergy’s perspective on the evolving demands for transparency and responsibility in business aligns seamlessly with NSF’s ethos. His anticipation to contribute to NSF’s critical role in setting and upholding standards across key industries reflects a forward-thinking approach to global health and safety.
Nancy Lurker: A Trailblazer in Pharmaceuticals and Biotechnology
Nancy Lurker’s appointment brings a wealth of experience from her time in leadership roles across the pharmaceutical and biotechnology sectors, including her recent position as CEO of EyePoint Pharmaceuticals Corporation. Her board memberships at EyePoint Pharmaceuticals Corporation and Altasciences, LLC, and advisory roles at Stanford School of Medicine and Novo Holdings, demonstrate her expansive influence in the field. Lurker’s academic credentials, an MBA from the University of Evansville and a Bachelor’s in Biology from Seattle Pacific University, further underscore her expertise.
Lurker’s acknowledgment of NSF’s pivotal role in independent testing and certification, and her commitment to advancing NSF’s mission of protecting health, resonate with the organization’s core values. Her pride in joining NSF’s Board is a testament to the organization’s impactful work.
A Strategic Enhancement for NSF’s Board
The addition of Bergy and Lurker to the NSF Board of Directors is more than just an expansion; it’s a strategic enhancement. Their combined experience and leadership are set to propel NSF’s mission forward, particularly in this landmark 80th year. For more insights and updates on NSF’s initiatives and its impact on global health and safety, stay tuned to IHRMAGAZINE.COM.
